コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ting in the morning with ambulatory one-lead ECG monitors.
2 thmia activity were assessed with telemetric ECG monitors.
3 6, 9, and 12 months using continuous 24-hour ECG monitors.
4 AF was detected by 4 weeks versus 2 weeks of ECG monitoring.
5 mptom-limited cycle ergometry during 12-lead ECG monitoring.
6 ve not used an implantable loop recorder for ECG monitoring.
7 with the standard practice of short-duration ECG monitoring.
8 tually demonstrate AF, such as on ambulatory ECG monitoring.
9 the modified V(5) position by 24-hour Holter ECG monitoring.
10 Patients underwent 48 h of ambulatory ECG monitoring.
11 e or frequency of ischemia during ambulatory ECG monitoring.
12 isode of ST-segment depression on ambulatory ECG monitoring.
13 electrophysiological study or by ambulatory ECG monitoring.
14 stic yield of 4 versus 2 weeks of continuous ECG monitoring.
15 and outcomes in patients who need ambulatory ECG monitoring.
16 ts were followed for 1 year using ambulatory ECG monitoring.
17 ther known AF (45%) or AF ruled out by 7-day ECG-monitoring.
18 mented with continuous electrocardiographic (ECG) monitoring.
19 ectrodes, enabling remote electrocardiogram (ECG) monitoring.
20 schemia who underwent 48 hours of ambulatory ECG monitoring, 58 patients exhibited ambulatory ischemi
23 d at least 24 hours of electrocardiographic (ECG) monitoring after an ischemic stroke to rule out atr
24 artery disease patients underwent ambulatory ECG monitoring and completed a structured diary assessin
25 Ischemia end points, including ambulatory ECG monitoring and exercise treadmill testing, and endot
26 -19 who were receiving continuous telemetric ECG monitoring and had a definitive disposition of hospi
27 d in an ancillary study involving ambulatory ECG monitoring and had follow-up for clinically detected
29 high (HF)-frequency heart rate variability, ECG monitoring, and the plasma markers von Willebrand fa
30 chemia on 48-h ambulatory electrocardiogram (ECG) monitoring, and resting and mental stress-induced l
33 tment regimens require electrocardiographic (ECG) monitoring due to the use of multiple QTc-prolongin
34 nts were on continuous electrocardiographic (ECG) monitoring during hospitalization and 12-lead ECG w
35 iac evaluation, including 24-hour ambulatory ECG monitoring, echocardiography, and exercise testing,
37 e 2-part intervention consisted of an online ECG monitoring education program and strategies to imple
39 Each patient underwent continuous 12-lead ECG monitoring for 36 to 72 hours with the Mortara ST mo
44 uidelines for the care of patients receiving ECG monitoring has led clinicians to rely too heavily on
45 significantly reduced ischemia on continuous ECG monitoring (Holter) at 48 hours compared with placeb
49 follow-up, only 2.6% and 9.7% had ambulatory ECG monitoring in the 7 days and 12 months post-stroke,
50 ved 25 minutes per week of continuous Holter ECG monitoring, including 5 minutes of rest, 5 minutes o
51 r acute cardiac ischemia, continuous 12-lead ECG monitoring increases the detection of diagnostic ECG
53 Although continuous electrocardiographic (ECG) monitoring is ubiquitous in hospitals, monitoring p
57 ial (3) short-duration monitors (24-/48-hour ECG monitors) missing a substantial proportion of recurr
59 item online test, quality of care related to ECG monitoring (N=4587 patients) by on-site observation,
60 We aimed to assess the effect of systematic ECG monitoring of patients in hospital on the rate of or
61 arrhythmic effects as assessed by continuous ECG monitoring of patients in the first week after admis
62 can Heart Association practice standards for ECG monitoring on nurses' knowledge, quality of care, an
63 However, we found no effect of systematic ECG monitoring on the rate of oral anticoagulant use aft
64 ng implantable loop recorders for continuous ECG monitoring post-AF ablation show that VLR occurs in
69 atively, 7 of 7 animals subjected to 24-hour ECG monitoring showed multiple ventricular premature dep
73 using multiple ECG recordings or continuous ECG monitoring to detect AF have failed to demonstrate a
75 ns were studied by transesophageal pacing or ECG monitoring to determine the mechanism of tachycardia
76 day continuous ambulatory electrocardiogram (ECG) monitoring, twice daily single-lead ECG or from car
77 ial fibrillation during at least 24 hours of ECG monitoring underwent randomization within 90 days af
78 (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Preven
79 (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Preven
80 (Atrial Fibrillation detected by Continuous ECG Monitoring using Implantable Loop Recorder to preven
81 (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Preven
82 (Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Preven
84 onitor-detected AF using a 14-day ambulatory ECG monitor was similar in the 4 race/ethnic groups: 7.1
86 ad ambulatory (Holter) electrocardiographic (ECG) monitoring was performed from 3 hours preinjection
88 Seattle Angina Questionnaire, and ambulatory ECG monitoring were used to assess responses at baseline
89 e ventriculography and electrocardiographic (ECG) monitoring were performed during the mental stress
91 to undergo additional noninvasive ambulatory ECG monitoring with either a 30-day event-triggered reco
93 48 hours of ambulatory electrocardiographic (ECG) monitoring with concurrent self-report measures of
94 participants who wore a leadless, ambulatory ECG monitor (Zio XT Patch) for up to 2 weeks were aged 7